SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                   FORM 8-K/A
                                 CURRENT REPORT

                                  (Amendment 1)

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



         Date of Report (Date of earliest event reported): May 28, 2003



                          Commission File No. 000-31727

                       TRANSFORM PACK INTERNATIONAL, INC.
        (Exact name of small business issuer as specified in its charter)

               Minnesota                               41-1886254
    (State or Other Jurisdiction of                   (IRS Employer
     Incorporation or Organization)                Identification No.)




                           12230 Forest Hill Boulevard
                                    Suite 157
                            Wellington, Florida 33414
                    (Address of principal executive offices)

                                 (561) 227-1597
                           (Issuer's telephone number)




                 929 Cedar Cove Road, Wellington, Florida 33414
         (Former name or former address, if changed since last report.)








Transform  Pack  International,  Inc., a Minnesota  corporation,  is filing this
amendment  to its Form 8-K dated May 28,  2003 in order to  provide  Item 7. (a)
Financial Statements of Business Acquired


ITEM 7.  Financial Statements and Exhibits

         (a) Financial Statements of Business Acquired.

            The audited financial statements of Quantum HIPAA Consulting Group,
         Inc. for the fiscal years ended October 31, 2002 and 2001

            The unaudited financial statements of Quantum HIPAA Consulting
         Group, Inc. for the six months ended April 30, 2003 and 2002, and for
         the period July 24, 2001 (inception) to April 30, 2003.

         (b) Pro Forma Financial Information.


            The pro forma balance sheets at April 30, 2003 and October 31, 2002.



                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                    Transform Pack International, Inc.


Date:  October 2, 2003              /s/ Noel J. Guillama, President


                                       2






                                TABLE OF CONTENTS



Independent Auditor's Report                                                   4


Financial Statements:


 Balance Sheets as of October 31, 2002 and 2001
   and unaudited as of April 30, 2003                                          5


 Statements of Operations for the year ended October 31, 2002, for the period
   July 24, 2001 (inception) to October 31, 2001, unaudited for the six
   months ended April 30, 2003 and 2002, and unaudited for the period July
   24, 2001 (inception) to April 30, 2003.                                     6


 Statements of Changes in Deficiency in Assets for the year ended October 31,
   2002, the for the period July 24, 2001 to October 31, 2001, and unaudited
   for the six months ended April 30, 2003                                     7


 Statements of Cash Flow for the year ended October 31, 2002, for the period
   July 24, 2001 (inception) to October 31, 2001, unaudited for the six
   months ended April 30, 2003 and 2002, and unaudited for the period July
   24, 2001 (inception) to October 31, 2003                                    8


 Notes to Financial Statements                                                 9




                                       3






                          INDEPENDENT AUDITOR'S REPORT

To the Board of Directors and Stockholders

Quantum HIPAA Consulting Group, Inc.



We have audited the  accompanying  balance  sheets of Quantum  HIPAA  Consulting
Group,  Inc.  as of October 31, 2002 and 2001,  and the  related  statements  of
operations,  changes in  deficiency  in assets and cash flows for the year ended
October 31, 2002 and for the period  July 24,  2001  (inception)  to October 31,
2001.  These  financial  statements  are  the  responsibility  of the  Company's
management.  Our  responsibility  is to express  an  opinion on these  financial
statements based on our audits.



We conducted our audits in accordance with auditing standards generally accepted
in the  United  States of  America.  Those  standards  require  that we plan and
perform the audits to obtain  reasonable  assurance  about whether the financial
statements are free of material misstatement.  An audit includes examining, on a
test basis,  evidence  supporting  the amounts and  disclosures in the financial
statements.  An audit also includes assessing the accounting principles used and
significant  estimates  made by  management,  as well as evaluating  the overall
financial  statement  presentation.   We  believe  that  our  audits  provide  a
reasonable basis for our opinion.



In our opinion,  the financial  statements  referred to above present fairly, in
all material respects, the financial position of Quantum HIPAA Consulting Group,
Inc. as of October 31, 2002 and 2001,  and the results of its operations and its
cash flows for the year ended  October 31, 2002 and for the period July 24, 2001
to October 31, 2001 in conformity with accounting  principles generally accepted
in the United States of America.



The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a  going  concern.  As  discussed  in  Note 1 to the
financial statements, the Company has suffered recurring losses and had negative
cash flows from  operations  which raise  substantial  doubt about the Company's
ability to continue as a going  concern.  Management's  plans in regard to these
matters  are  also  described  in the Note 1. The  financial  statements  do not
include any adjustments that might result from the outcome of this uncertainty.





/s/ Daszkal Bolton LLP



Boca Raton, Florida

September 9, 2003



                                       4






                      Quantum HIPAA Consulting Group, Inc.
                        ( A Development Stage Enterprise)
                                  Balance Sheet


                                         October 31,   October 31,    April 30,
                                            2002          2001          2003
                                         -----------   -----------   -----------
                                                                     (unaudited)

ASSETS

Current assets:
   Cash                                  $        -    $      555    $        -
                                         -----------   -----------   -----------
   Total current assets                           -           555             -

Property and equipment, net of
 accumulated depreciation of
 $1,657, $414 and $2,279                      2,072         3,315         1,450
Other assets                                  1,820         1,820
                                         -----------   -----------   -----------
Total assets                             $    3,892    $    5,690    $    1,450
                                         ===========   ===========   ===========


LIABILITIES AND SHAREHOLDERS' DEFICIT

Current liabilities:
   Accounts payable and accrued
    liabilities                          $   18,788    $   25,006    $   71,245
   Loan payable - shareholder               179,080        88,260       183,612
                                         -----------   -----------   -----------

Total current liabilities                   197,868       113,266       254,857


Commitments and contingencies


Deficiency in assets                       (193,976)     (107,576)     (253,407)
                                         -----------   -----------   -----------
Total liabilities and deficiency in
 assets                                  $    3,892    $    5,690    $    1,450
                                         ===========   ===========   ===========

                See accompanying notes to financial statements.

                                       5





                      Quantum HIPAA Consulting Group, Inc.
                        (A Development Stage Enterprise)
                             Statement of Operations





                                             For the period
                           For the year    from July 24, 2001     For the six month ended      July 24, 2001
                              ended          (inception) to    ------------------------------  (inception) to
                         October 31, 2002   October 31, 2001   April 30, 2003  April 30, 2002  April 20, 2003
                         ----------------  ------------------  --------------  --------------  --------------
                                                                (unaudited)     (unaudited)      (unaudited)
                                                                                
Expenses Representing
 Net Loss                $       (86,400)  $        (127,576)  $     (59,431)  $     (48,134)  $    (273,407)
                         ================  ==================  ==============  ==============  ==============






Basic and diluted
 loss per common share   $        (0.004)  $          (0.006)  $      (0.003)  $      (0.002)  $      (0.014)
                         ================  ==================  ==============  ==============  ==============

Weighted average number
 of common shares
 outstanding                  20,000,000          20,000,000      20,000,000      20,000,000      20,000,000
                         ================  ==================  ==============  ==============  ==============



                See accompanying notes to financial statements.

                                       6





                      Qunatum HIPAA Consulting Group, Inc.
                        (A Development Stage Enterprise)
                  Statement of Changes in Deficiency in Assets


                            Common Stock                  Accumulated
                     par value $.001 per share              Deficit
                       90,000,000 authorized   Additional   During
                     -------------------------  Paid-in   Development   Total
                     # of Shares     Amount     Capital      Stage    Deficiency
                     ------------ ------------ ---------- ----------- ----------

Balance 7/24/01
      (inception)               - $          - $        - $        -  $       -


Sale of common stock   20,000,000 $     20,000 $        -                20,000
Net Loss                                                  $ (127,576)  (127,576)
                     ------------ ------------ ---------- ----------- ----------
Balance 10/31/01       20,000,000 $     20,000 $        - $ (127,576) $(107,576)

Net Loss                                                  $  (86,400) $ (86,400)
                     ------------ ------------ ---------- ----------- ----------
Balance at 10/31/02    20,000,000 $     20,000 $        - $ (213,976) $(193,976)


Unaudited:

Net Loss                                                  $  (59,431)   (59,431)
                     ------------ ------------ ---------- ----------- ----------
Balance at 4/30/03     20,000,000       20,000 $        - $ (273,407) $(253,407)
                     ============ ============ ========== =========== ==========











                 See accompanying notes to financial statements.


                                       7






                      Quantum HIPAA Consulting Group, Inc.
                        (A Development Stage Enterprise)
                             Statements of Cash Flow



                                           For the period
                                         from July 24, 2001  Six months  Six months  July 24, 2001
                            Year ended     (inception to       ended       ended     (inception) to
                            October 31,     October 31,       April 30    April 30      April 30
                                2002           2001             2003        2002          2003
                            -----------  ------------------  ----------  ----------  --------------
                                                             (unaudited) (unaudited)  (unaudited)

                                                                      
OPERATING ACTIVITIES
 Net (loss)                 $  (86,400)  $        (127,576)  $ (59,431)  $ (48,134)  $    (273,407)
                            -----------  ------------------  ----------  ----------  --------------
 Adjustments to reconcile
   net loss to net cash used
   in operating activities:
    Depreciation and
    amortization                 1,243                 414         622         622           2,279

 Changes in operating
  assets and liabilities:
   (Increase) decrease in
    other assets                                    (1,820)      1,820
   Increase (decrease) in
    accounts payable
    and accrued liabilities     (6,218)             25,007      52,457     (16,528)         71,246
                            -----------  ------------------  ----------  ----------  --------------
   Total adjustments            (4,975)             23,601      54,899     (15,906)         73,525
                            -----------  ------------------  ----------  ----------  --------------

    Net cash used in
    operating activities       (91,375)           (103,975)     (4,532)    (64,040)       (199,882)

INVESTING ACTIVITIES
 Purchase of property and
  equipment                                         (3,730)                                 (3,730)
 Investment in related
  companies
                            -----------  ------------------  ----------  ----------  --------------
  Net cash (used in)
  investing activities               -              (3,730)          -           -          (3,730)
                            -----------  ------------------  ----------  ----------  --------------

FINANCING ACTIVITIES
 Proceeds from loan
  payable- shareholder          90,820              88,260       4,532      63,485         183,612
 Proceeds from issuance of
  common stock                                      20,000                                  20,000
                            -----------  ------------------  ----------  ----------  --------------
Net cash provided by
 financing activities           90,820             108,260       4,532      63,485         203,612
                            -----------  ------------------  ----------  ----------  --------------

Net increase (decrease) in
 cash                             (555)                555           0        (555)             (0)

Cash at beginning of period        555                   -           -         555               -
                            -----------  ------------------  ----------  ----------  --------------

Cash at end of period       $       (0)  $             555   $       0   $      (0)  $          (0)
                            ===========  ==================  ==========  ==========  ==============


 Supplemental disclosures
  of cash flow information:

   Cash paid during the
    period for interest     $        -   $               -   $       -   $       -   $           -




                    See accompanying notes to financial statements.

                                       8




QUANTUM HIPAA CONSULTING GROUP, INC.
(A DEVELOPMENT STAGE ENTERPRISE)
NOTES TO FINANCIAL STATEMENTS



NOTE 1:  DESCRIPTION OF COMPANY

Quantum HIPAA  Consulting  Group,  Inc. was  incorporated  on July 24, 2001. The
Company is a development  stage  enterprise  which was formed to provide medical
practice and HIPAA compliance consulting services to the health care industry.

The  accompanying  financial  statements  reflect ongoing losses,  negative cash
flows from operating  activities,  negative  working  capital and  shareholders'
deficit.

The Company has no revenues to date.  Since its inception,  the Company has been
dependent  upon  the  receipt  of  capital  investment  to fund  its  continuing
activities.  In  addition to the normal  risks  associated  with a new  business
venture,  there can be no assurance  that the  Company's  business  plan will be
successfully  executed. The Company's ability to execute its business model will
depend on its ability to obtain  additional  financing  and achieve a profitable
level of operations. There can be no assurance that sufficient financing will be
obtained.  Nor  can any  assurance  be  made  that  the  Company  will  generate
substantial   revenues  or  that  the  business  operations  will  prove  to  be
profitable. These conditions raise substantial doubt about the Company's ability
to continue as a going  concern.  The  financial  statements  do not include any
adjustments that might result from the outcome of these uncertainties.


NOTE 2:  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Cash Equivalents

The  Company   considers  all  highly  liquid  debt  instruments  with  original
maturities  of three months or less to be cash  equivalents.  For the six months
ended July 31, 2003 and 2002, there were no cash equivalents.

Property and Equipment

Furniture and equipment are stated at cost. Depreciation is calculated using the
straight-line  method over the estimated useful lives of the assets, which range
from three to five years.

Research and Development Costs

Research and development costs are charged to expense when incurred.

Use of Estimates

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  the  reported  amounts  of assets  and  liabilities  and  disclosure  of
contingent  assets and  liabilities at the date of the financial  statements and
the reported amount of revenues and expenses during the reporting period. Actual
results could differ from those estimates and the differences could be material.

                                       9




QUANTUM HIPAA CONSULTING GROUP, INC.
(A DEVELOPMENT STAGE ENTERPRISE)
NOTES TO FINANCIAL STATEMENTS


NOTE 2:  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Income Taxes

The Company  has not  recognized  any benefit of start up cost or net  operating
loss  carry  forwards,  totaling  approximately  $255,000,  in the  accompanying
financial  statements in accordance  with the provisions of SFAS No. 109, as the
realization  of this  deferred  tax  benefit  is not  likely.  A 100%  valuation
allowance  has been  recognized to offset the entire effect of the Company's net
deferred tax asset. The net operating losses will expire in 2021 and 2022.

Recent Accounting Pronouncements

In June 2001, the Financial Accounting Standards Board ("FASB") issued Statement
of Financial  Accounting Standards (" SFAS ') No. 143 which requires entities to
record the fair value of a liability for an asset  retirement  obligation in the
period in which it is incurred  and a  corresponding  increase  in the  carrying
amount of the related long-lived asset. Subsequently,  the asset retirement cost
should be allocated to expense using a systematic  and rational  method over its
useful life. SFAS No. 143 is effective for fiscal years beginning after June 15,
2002.  Adoption of SFAS No. 143 did not have a material  impact on the Company's
financial statements.

In June 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with
Exit or Disposal  Activities.  This statement addresses accounting and reporting
for costs  associated  with exit or disposal  activities and nullifies  emerging
issues  Task Force  Issue No.  94-3.  The  statement  is  effective  for exit or
disposal  costs  initiated  after  December  31,  2002,  with early  application
encouraged.  The Company adopted SFAS No. 146 effective  January 1, 2003,  which
did not have a material impact on the Company's financial statements.

In December  2002,  the FASB issued SFAS No.  148,  Accounting  for  Stock-Based
Compensation-Transition  and Disclosure-an  amendment of FASB Statement No. 123.
This statement provides alternative methods of transition for a voluntary change
to  the  fair  value  based  method  of  accounting  for  stock-based   employee
compensation.  Adoption  of SFAS No. 148 did not have a  material  impact on the
Company's financial statements.

                                       10




QUANTUM HIPAA CONSULTING GROUP, INC.
(A DEVELOPMENT STAGE ENTERPRISE)
NOTES TO FINANCIAL STATEMENTS



NOTE 2:  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

In May 2003,  the FASB issued SFAS No. 150,  "Accounting  For Certain  Financial
Instruments with  Characteristics of both Liabilities and Equity".  SFAS No. 150
changes the accounting for certain financial instruments with characteristics of
both liabilities and equity that, under previous  pronouncements,  issuers could
account for as equity.  The new  accounting  guidance  contained in SFAS No. 150
requires that those  instruments  be classified  as  liabilities  in the balance
sheet.  SFAS  No.  150  affects  the  issuer's  accounting  for  three  types of
freestanding  financial  instruments.  One type is mandatory  redeemable shares,
which the issuing company is obligated to buy back in exchange for cash or other
assets. A second type includes put options and forward purchase contracts, which
involve  instruments  that do or may  require the issuer to buy back some of its
shares in exchange for cash or other assets.  The third type of instruments that
are  liabilities  under this Statement is  obligations  that can be settled with
shares,  the monetary value of which is fixed, tied solely or predominantly to a
variable  such as a market  index,  or  varies  inversely  with the value of the
issuers' shares. SFAS No. 150 does not apply to features embedded in a financial
instrument  that is not a derivative in its entirety.  Most of the provisions of
SFAS No. 150 are consistent with the existing  definition of liabilities in FASB
Concepts  Statement  No. 6,  "Elements of Financial  Statements".  The remaining
provisions of this Statement are consistent  with the FASB's  proposal to revise
that definition to encompass certain  obligations that a reporting entity can or
must settle by issuing its own shares.  This  Statement  shall be effective  for
financial  instruments entered into or modified after May 31, 2003 and otherwise
shall be effective at the beginning of the first interim period  beginning after
June 15,  2003,  except for  mandatory  redeemable  financial  instruments  of a
non-public  entity,  as to  which  the  effective  date  is for  fiscal  periods
beginning after December 15, 2003. The Company is currently assessing the impact
of SFAS  No.  150,  which  is not  expected  to have a  material  impact  on the
Company's financial statements.

Interim Financial  Information for the Six Month Period Ended April 30, 2003 and
2002

The information presented as of April 30, 2003 and 2002 has not been audited. In
the opinion of management,  the unaudited interim financial  statements  include
all adjustments,  consisting only of normal recurring adjustments,  necessary to
present fairly the Company's  financial  position as of April 30, 2003 and 2002,
and the results of its  operations  and its cash flows for the six months  ended
April 30, 2003 and 2002, and the stockholders'  deficit for the six months ended
April 30, 2003.  The results of operations for the six months period ended April
30, 2003 are not necessarily indicative of the results for the full year.

NOTE 3: COMMITMENTS

As of October 31, 2002, the Company had commitments  under operating  leases for
premises,  maturing  December 31, 2002.  Rent expense for the year ended October
31, 2002 was $18,447.

NOTE 4: RELATED PARTY TRANSACTIONS

From inception, July 24, 2001 through October 31, 2002, the sole shareholder has
advanced to the Company $179,080, which is non-interest bearing. (See Note 5)

                                       11




QUANTUM HIPAA CONSULTING GROUP, INC.
(A DEVELOPMENT STAGE ENTERPRISE)
NOTES TO FINANCIAL STATEMENTS



NOTE 5: SUBSEQUENT EVENTS

On November 1, 2002, the Company entered into an agreement with a shareholder to
purchase certain  intellectual  property integral to the Company's business.  In
exchange, the company issued a three (3) year installment note for $179,080 with
an interest rate of eighteen  percent (18%) per annum. The price of the sale was
equal to the cost the  shareholder  incurred to develop the property  purchased.
The note is payable monthly  starting  January 2003. The Company is in technical
default as no  payments  have been made on the note.  The  Company  is  accruing
interest,  at 18% per annum,  monthly on the unpaid  principal  balance  and has
classified the note as current as per the agreement.

On November 2, 2002 the Company  signed a demand note,  with an interest rate of
eighteen  percent (18%) per annum, for the expenses a shareholder paid on behalf
of the Company  subsequent to the sale of the  intellectual  property.  The note
balance as of April 30, 2003 was $4,532.

Effective May 28, 2003,  the Company  consummated a merger  pursuant to a merger
agreement   with  Transform   Pack   International,   Inc.  The  Transform  Pack
International, Inc. completed the merger by issuing 27,000,000 million shares of
Common  Stock,  in  exchange  for all the issued and  outstanding  shares of the
Company.  For  accounting  purposes,  the  acquisition  will  be  treated  as  a
recapitalization  of the  Company.  The value of the net  assets of the  Company
after the acquisition was completed is the same as their historic book value.

In July 2003, the Company purchased a 20% interest  Renaissance  Health Systems,
Inc. for $5,000 from a shareholder of the Company. Renaissance Health Systems is
a development  stage enterprise in the health care business.  Additionally,  the
Company  purchased a 20%  interest in Quantum  Medical  Technologies,  Inc.  for
$5,000 from a shareholder of the Company. Quantum Medical Technologies,  Inc. is
a development stage enterprise in the medical technologies business.

                                       12




                         Pro Forma Financial Information

   Transform Pack International, Inc. and Quantum HIPAA Consulting Group, Inc.
                     Introduction to Pro Forma Balance Sheet
                                   (Unaudited)






On May 28, 2003 a majority of the shareholders of Transform Pack  International,
Inc.  approved  an  Agreement  and  Plan  of  Exchange  between  Transform  Pack
International,  Inc. and Quantum HIPAA Consulting  Group, Inc. whereby Transform
Pack  International,  Inc.  issued  27,000,000  shares  of its  Common  Stock in
exchange for all of the  outstanding  common stock of Quantum  HIPAA  Consulting
Group, Inc.

The following Pro Forma Combined Balance Sheets of the Registrant are reflective
of the year end change to October  31st,  as filed on 8-K dated  August 29, 2003
and have been prepared by management  of the  Registrant  based upon the balance
sheets of the  Registrant  as of August 31,  2002 and  February  28, 2003 and of
Quantum HIPAA Consulting  Group, Inc. as of October 31, 2002 and April 30, 2003.
For accounting  purposes,  the acquisition has been treated as an acquisition of
Transform Pack  International,  Inc. by Quantum HIPAA Consulting Group, Inc. and
as a  recapitalization  of Quantum HIPAA  Consulting  Inc. The pro forma balance
sheet  gives  effect  to the  transaction  as a  public  shell  merger  and  the
assumptions  and  adjustments  in the  accompanying  notes to pro forma combined
balance  sheets.  The pro forma  combined  balance  sheet as of October 31, 2002
gives effect to the transaction as if it had occurred as of August 31, 2002. The
pro forma  combined  balance  sheet as of April  30,  2003  gives  effect to the
proposed transaction as if it had occurred as of February 28, 2003.

The pro forma  adjustments  are based upon  available  information  and  certain
assumptions  that  management  believes are  reasonable.  The pro forma combined
balance  sheets  do not  purport  to  represent  what  the  combined  companies'
financial  position  would  actually  have  been  had the  proposed  transaction
occurred  on such date or as of the  beginning  of the period  indicated,  or to
project the combined companies' financial position for any future period.


                                       13





   Transform Pack International, Inc. and Quantum HIPAA Consulting Group, Inc.
                   Pro Forma Condensed Combined Balance Sheet
                                October 31, 2002
                                   (Unaudited)

                                     ASSETS


                                    Historical
                              ------------------------
                                October    August 31,
                               31, 2002      2002                      Pro Forma       Pro Forma
                                Quantum    Transform     Combined     Adjustments       Combined
                              -----------  -----------  -----------  -------------    ------------
                                                                       
CURRENT ASSETS
Cash                                       $        -   $        -                    $         -
Inventory                              -       76,363       76,363        (76,363)              -
Prepaid expenses and other
 assets                                -        4,597        4,597   $     (4,597)              -
Accounts recievable                    -      127,694      127,694       (127,694)              -
                              -----------  -----------  -----------  -------------    ------------
      Total Current Assets             -      208,654      208,654       (208,654)              -
                              -----------  -----------  -----------  -------------    ------------

PROPERTY & EQUIPMENT - NET         2,072      381,553      383,625       (381,553)          2,072
                              -----------  -----------  -----------  -------------    ------------
OTHER ASSETS
Other assets                       1,820                     1,820                          1,820
Investment in affiliate                -        2,000        2,000         (2,000)              -
                              -----------  -----------  -----------  -------------    ------------
      Total Other Assets           1,820        2,000        3,820         (2,000)          1,820

TOTAL ASSETS                  $    3,892   $  592,207   $  596,099   $   (592,207)    $     3,892
                              ===========  ===========  ===========  =============    ============

                  LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES:
Cash overdraft                $        -   $  429,221   $  429,221   $   (429,221)    $        -
Accounts payable                  18,788      445,516      464,304       (324,664)(b)     139,640
Current-portion - LT debt              -       66,951       66,951        (66,951)              -
Current-portion - redeemable
 preferred shares                             120,000      120,000       (120,000)              -
Loan payable                     179,080                   179,080                        179,080
                                       -            -            -              -               -
                              -----------  -----------  -----------  -------------    ------------
      Total Current
       Liabilities               197,868    1,061,688    1,259,556       (940,836)        318,720
                              -----------  -----------  -----------  -------------    ------------

Long-term debt                         -      806,323      806,323       (806,323)              -
Due to shareholder                     -      221,077      221,077       (221,077)              -
                              -----------  -----------  -----------  -------------    ------------
     Total Long-term
      Liabilities                      -    1,027,400    1,027,400     (1,027,400)              -

Shareholders' Equity
 (Deficit):
Common stock                      20,000    2,080,812    2,100,812     (1,972,376) (a)    128,436
Additional paid in capital             -                         -       (229,288) (a)   (229,288)
Retained Earnings               (213,976)  (3,577,693)  (3,791,669)     3,577,693        (213,976)
                              -----------  -----------  -----------  -------------    ------------
  Total Shareholders' Equity
   (Deficit)                    (193,976)  (1,496,881)  (1,690,857)     1,376,029        (314,828)
                              -----------  -----------  -----------  -------------    ------------

TOTAL LIABILITIES &
 SHAREHOLDERS' EQUITY
 (DEFICIT)                    $    3,892   $  592,207   $  596,099   $   (592,207)    $     3,892
                              ===========  ===========  ===========  =============    ============


                    See notes to pro forma condensed balance sheets.

                                       14




     Transform Pack International, Inc. and Quantum HIPAA Consulting Group, Inc.
                     Pro Forma Condensed Combined Balance Sheet
                                   April 30, 2003
                                     (Unaudited)

                                     ASSETS


                                    Historical
                              ------------------------
                               4/30/2003    2/28/2003                  Pro Forma       Pro Forma
                                Quantum     Transform    Combined     Adjustments       Combined
                              -----------  -----------  -----------  -------------    ------------
                                                                       
CURRENT ASSETS
Cash                                       $   50,261   $   50,261   $    (50,261)    $         -
Inventory                                      40,347       40,347        (40,347)              -
Prepaid expenses and other
 assets                                           922          922           (922)              -
                                       -            -            -              -               -
                              -----------  -----------  -----------  -------------    ------------
      Total Current Assets             -       91,530       91,530        (91,530)              -

PROPERTY & EQUIPMENT - NET         1,450      350,787      352,237       (350,787)          1,450
                              -----------  -----------  -----------  -------------    ------------

OTHER ASSETS
  Seccurity deposits                   -                         -              -               -
Investment in affiliate                -        2,000        2,000         (2,000)              -
                              -----------  -----------  -----------  -------------    ------------
      Total Other Assets               -        2,000        2,000         (2,000)              -

TOTAL ASSETS                  $    1,450   $  444,317   $  445,767   $   (444,317)    $     1,450
                              ===========  ===========  ===========  =============    ============

                    LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Cash overdraft                $        -   $  426,004   $  426,004   $   (426,004)    $         -
Accounts payable                  71,245      364,216      435,461       (243,364) (b)    192,097
Current-portion - LT debt              -       66,951       66,951        (66,951)              -
Current-portion - redeemable
 preferred shares                             566,250      566,250       (566,250)              -
Loan payable                     183,612            -      183,612              -         183,612
                              -----------  -----------  -----------  -------------    ------------
      Total Current
       Liabilities               254,857    1,423,421    1,678,278     (1,302,569)        375,709
                              -----------  -----------  -----------  -------------    ------------

Long-term debt                         -      406,760      406,760       (406,760)              -
Due to shareholder                     -      231,077      231,077       (231,077)              -
                              -----------  -----------  -----------  -------------    ------------
     Total Long-term
      Liabilities                      -      637,837      637,837       (637,837)              -

Shareholders' Equity
 (Deficit):
Common stock                      20,000    2,130,820    2,150,820     (2,022,384) (a)    128,436
Additional paid in capital                                       -       (229,288) (a)   (229,288)
Retained Earnings               (273,407)  (3,747,761)  (4,021,168)     3,747,761        (273,407)
                              -----------  -----------  -----------  -------------    ------------
  Total Shareholders'Equity
   (Deficit)                    (253,407)  (1,616,941)  (1,870,348)     1,496,089        (374,259)
                              -----------  -----------  -----------  -------------    ------------
TOTAL LIABILITIES &
 SHAREHOLDERS' EQUITY
 (DEFICIT)                    $    1,450   $  444,317   $  445,767   $   (444,317)    $     1,450
                              ===========  ===========  ===========  =============    ============


                See notes to pro forma condensed balance sheets.

                                       15




Notes to Pro Forma Condensed Balance Sheets (Unaudited)


The pro forma  balance  sheet at April  30,  2003 is based on the  period  ended
February  28,  2003 for the  registrant  and April 30,  2003 for  Quantum  HIPAA
Consulting  Group,  Inc. The pro forma  balance  sheet gives effect to the share
exchange as if it had occurred on February 28, 2003. The pro forma balance sheet
at  October  31,  2002 is based on the  period  ended  August  31,  2002 for the
registrant and October 31, 2002 for Quantum HIPAA Consulting Group, Inc. The pro
forma balance sheet gives effect to the share  exchange as if it had occurred on
August 31, 2002.

(a) Reflects the  accounting for the merger of Quantum HIPAA  Consulting  Group,
Inc.,  which  consists of issuance of 27,000,000  shares of common stock and the
cancellation of 7,000,000 for the disposition of the operating subsidiary as per
the merger agreement.

(b) Reflects  assumption of $112,036 of the registrant's  payables and $8,816 of
merger related expenses

                                       16